85
Participants
Start Date
Not specified
Study Completion Date
February 29, 2000
Zidovudine
Didanosine
Beth Israel Med Ctr, New York
Bellevue Hosp / New York Univ Med Ctr, New York
Jack Weiler Hosp / Bronx Municipal Hosp, The Bronx
Univ of Rochester Medical Center, Rochester
Johns Hopkins Hosp, Baltimore
Univ of Alabama at Birmingham, Birmingham
Methodist Hosp of Indiana / Life Care Clinic, Indianapolis
Northwestern Univ Med School, Chicago
Cook County Hosp, Chicago
Rush Presbyterian - Saint Luke's Med Ctr, Chicago
Louis A Weiss Memorial Hosp, Chicago
Univ of Colorado Health Sciences Ctr, Denver
Univ of North Carolina, Chapel Hill
Univ of Miami School of Medicine, Miami
Ohio State Univ Hosp Clinic, Columbus
Univ of Cincinnati, Cincinnati
Indiana Univ Hosp, Indianapolis
Illinois Masonic Med Ctr, Chicago
San Francisco Gen Hosp, San Francisco
Univ of Washington, Seattle
Harvard (Massachusetts Gen Hosp), Boston
Brigham and Women's Hosp, Boston
Collaborators (2)
Bristol-Myers Squibb
INDUSTRY
Glaxo Wellcome
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH